HOUSTON, May 30, 2025 /PRNewswire/ -- ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, announced today that a Trial in Progress poster for its ...
Nearly a year ago, Tennessee became the first state in the U.S. to scrap residency requirements for certain international medical graduates (IMGs), opening up an alternative pathway to permanent ...
A new study evaluated the effects of citizenship status on physician specialty choice and practice location among U.S. citizen and non-citizen international medical graduates (IMGs), which account for ...
“We are encouraged by the early performance of IMGS-001 as we proceed with Phase 1 dose escalation in patients with a variety of advanced solid tumors,” said James Barlow, President and CEO of ...
Overseas doctors are keeping the NHS running, but many say they are not getting the recognition or support they deserve. More than two thirds of doctors who joined the General Medical Council (GMC) ...
Hosted on MSN
It was a rough match day for family medicine, IMGs
This year's Match Day proved rough for two groups: family medicine and noncitizen international medical graduates (IMGs), according to data from the National Resident Matching Program (NRMP). The ...
IMGS-001 is first dual-specific PD-L1/PD-L2 antibody with cytotoxic killing function and is designed to treat the many "immune-excluded" cancers that are resistant to existing immunotherapies HOUSTON, ...
HOUSTON, May 01, 2025 (GLOBE NEWSWIRE) -- ImmunoGenesis, a clinical-stage biotechnology company developing innovative, science-driven immune therapies, and Cancer Focus Fund, LP, a unique investment ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results